19 to be independent predictors for incident CVD. In response to the recent rise of CVDs in developing countries, the World Health Organization (WHO) has identified very cost-effective interventions that are applicable even in low-resource settings for prevention and control of CVDs.
Although the WHO predicts a rapid increase of CVDs in SSA by 2030, researchers perceive that CVDs are not a priority public health problem in the region.
21 This perception is undermining the existing burden of the problem in this continent. Despite CVDs continuing to devastate human survival through the premature deaths of its workforce in developing countries, the few studies in Ethiopia have been limited to cross-sectional studies, which alone are insufficient to assess the risk of incident cardiovascular events. Therefore, we determined the incidence and predictors of cardiovascular disease among diabetic patients, from 2012 to 2020.
Go to
Brief Summary:
Current data estimated that 451 million people, (age 18-99 years) suffered from diabetes world wide in 2017, and are expected to rise to 693 million by 2045. Among them, type 2 diabetes mellitus (T2DM) accounts for around 90% of all cases with diabetes.
T2DM is associated with several deterimental microvascular and macrovascular complications (Annani-Akollor ME et al ., 2019) . As such, effective management of the disease is crucial.
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend metformin as the first therapeutic choice for T2DM management with concurrent lifestyle modifications. Reports indicated that metformin improves peripheral insulin sensitivity and reduces the risk of cardiovascular mortality in T2DM in addition to its beneficial effects on weight loss and vascular protection.
From diabetes to cancer and dementia, scientists are developing surprising new ways to spot illnesses early Engineers at in Japan are developing a device that uses tears to detect breast cancer John Naish
Tears contain markers that can be used for diagnosing a broad range of diseases
HERE’S a good reason to start crying with happiness: your tears could soon save your life by providing an early warning of cancer, diabetes and autoimmune disease.
In future, they may even predict your risk of developing Alzheimer’s. And tears are not the only bodily secretions that are being used in a new generation of painless diagnostic tests. Scientists say we can also use earwax, sweat and nasal mucus to detect everything from depression to gout.
Scientists say crying could save your life
Your tears could provide an early warning of cancer, diabetes and autoimmune disease
Published:
Tags:
Scientists are developing new ways to spot illnesses early, and they say crying could save your life.
According to an article from the daily mail, your tears could provide an early warning for cancer, diabetes, autoimmune disease and even predict your risk of developing Alzheimer’s.
Engineers at Kobe University in Japan are actually developing a device that uses tears to detect breast cancer quickly and easily.
They say our tears are made from precious traces of chemicals in our bodies that can be used as markers of illness.
Promising Data on Once-Weekly Insulin, Phase 3 Study Ongoing medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.